首页> 外国专利> OSTEOGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS USING HISTONE DEACETYLASE INHIBITORS

OSTEOGENIC DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS USING HISTONE DEACETYLASE INHIBITORS

机译:使用组蛋白去乙酰化肽抑制剂抑制人间充质干细胞成骨分化

摘要

The invention of bone mesenchymal stem cells (MSC) by the histone deacetylase (HDAC) inhibitors relates to a processing method of the differentiation inducing action and HDAC inhibitors . ; According to the present invention , pre-treatment of HDAC inhibitors can be seen that significantly increasing the bone cell differentiation inducing effect on the mesenchymal stem cells . Thus, it is possible by the HDAC inhibitors HDAC inhibitors were prepared on the basis that promote the differentiation of bone marrow cells used for bone regeneration technology development with differentiation inducers .
机译:组蛋白脱乙酰基酶(HDAC)抑制剂发明的骨间充质干细胞(MSC)涉及分化诱导作用和HDAC抑制剂的加工方法。 ;根据本发明,可以看出HDAC抑制剂的预处理显着增加了对间充质干细胞的骨细胞分化诱导作用。因此,有可能通过HDAC抑制剂在促进具有分化诱导剂的骨再生技术发展的基础上制备HDAC抑制剂,所述骨髓细胞用于骨髓再生。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号